M. Petsch

Fosfomycin

Fosfomycin: an old, new friend?

Industrial biocatalysis today and tomorrow

The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How

Preparation of human metabolites of propranolol using laboratory‐evolved bacterial cytochromes P450

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

In Vivo Microdialysis to Measure Antibiotic Penetration Into Soft Tissue During Cardiac Surgery

Principles of Antibiotic Penetration into Abscess Fluid

Tuberculosis and lung damage: from epidemiology to pathophysiology

Illumination of growth, division and secretion by metabolic labeling of the bacterial cell surface

Enantioselective Epoxidation of Terminal Alkenes to (R)‐ and (S)‐Epoxides by Engineered Cytochromes P450 BM‐3

Characterization of phosphonium ionic liquids through a linear solvation energy relationship and their use as GLC stationary phases

Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology

High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection

A genetically encoded photosensitizer

Stereoselective hydroxylation of an achiral cyclopentanecarboxylic acid derivative using engineered P450s BM-3

High-Sensitivity MALDI-MRM-MS Imaging of Moxifloxacin Distribution in Tuberculosis-Infected Rabbit Lungs and Granulomatous Lesions

Room-Temperature Ionic Liquids: Solvents for Synthesis and Catalysis. 2

Clinical practice guidelines for antimicrobial prophylaxis in surgery

Enantioselective α-Hydroxylation of 2-Arylacetic Acid Derivatives and Buspirone Catalyzed by Engineered Cytochrome P450 BM-3

International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

Bacterial Antibiotic Resistance: The Most Critical Pathogens

The Immune Response in Tuberculosis

The Future of Golgi Research

Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections

Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis

New photosensitizers for photodynamic therapy

2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa

Engineering Cytochrome P450 BM3 for Terminal Alkane Hydroxylation

Activatable Photosensitizers for Imaging and Therapy

The Fluorescent Toolbox for Assessing Protein Location and Function

Preparation of optically active N-benzyl-3-hydroxypyrrolidine by enzymatic hydroxylation

Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy

Antimicrobial Resistance in ESKAPE Pathogens

Stereoselective Hydroxylation of an Achiral Cyclopentanecarboxylic Acid Derivative Using Engineered P450s BM‐3.

Preparation and characterization of fused-silica capillary columns coated with m-carborane–siloxane copolymers for gas chromatography

Determination of fosfomycin in pus by capillary zone electrophoresis

Strategies for the determination of cefazolin in plasma and microdialysis samples by short‐end capillary zone electrophoresis

Microbial hydroxylation of 2-cycloalkylbenzoxazoles. Part III. Determination of product enantiomeric excess and cleavage of benzoxazoles

Antibiotic Abscess Penetration: Fosfomycin Levels Measured in Pus and Simulated Concentration-Time Profiles

Labeling of Capsid Proteins and Genomic RNA of Human Rhinovirus with Two Different Fluorescent Dyes for Selective Detection by Capillary Electrophoresis

Microbial hydroxylation of 2-cycloalkylbenzoxazoles. Part I. Product spectrum obtained from Cunninghamella blakesleeana DSM 1906 and Bacillus megaterium DSM 32

Microbial hydroxylation of 2-cycloalkylbenoxazoles. Part II. Determination of product structures and enhancement of enantiomeric excess